Author:
Chiyoda Tatsuyuki,Dozen Ai,Saotome Keiko,Nanki Yoshiko,Aoki Daisuke
Reference111 articles.
1. GLOBOCAN. Estimated cancer incidence, mortality and prevalence worldwide in 2012. Available from http://globocan.iarc.fr/Pages/fact_sheets_population.aspx (2012).
2. Gilks CB, Prat J. Ovarian carcinoma pathology and genetics: recent advances. Hum Pathol. 2009;40(9):1213–23.
3. Yang WL, Lu Z, Bast RC Jr. The role of biomarkers in the management of epithelial ovarian cancer. Expert Rev Mol Diagn. 2017;17(6):577–91.
4. Bast RC Jr, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest. 1981;68(5):1331–7.
5. Kabawat SE, Bast RC Jr, Bhan AK, Welch WR, Knapp RC, Colvin RB. Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125. Int J Gynecol Pathol. 1983;2(3):275–85.